First Eagle Value in Biotechnology Master Fund, Ltd., 10% Owner at DURECT CORP (DRRX), bought 4,000,000 shares at $0.52 ($2.1M) on 2019-06-20, disclosed to the SEC on 2019-06-24.
Open-market purchase of $2.1M DRRX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| DRRX | BUY | 2016-04-27 | $6.9M | — | Filing → |
| DRRX | BUY | 2015-03-20 | $2.8M | — | Filing → |